In a report released today, David Scharf from JMP Securities maintained a Hold rating on Oportun Financial (OPRT – Research Report). The ...
Wells Fargo analyst Mohit Bansal upgraded Jazz Pharmaceuticals (JAZZ) to Overweight from Equal Weight with a price target of $170, up from ...
Wells Fargo analyst Mohit Bansal raised the firm’s price target on Gilead (GILD) to $120 from $105 and keeps an Overweight rating on the ...
Wells Fargo analyst Mohit Bansal notes Travere Therapeutics (TVTX) plans to submit on Phase 3 DUPLEX study after FDA meeting. The company plans ...
Sara Ali Khan's latest Instagram post is all about love, laughter and wedding vibes. The actress dropped a carousel of ...
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Merck & Company (MRK – Research Report), with a ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...
Wells Fargo analyst Mohit Bansal lowered the firm’s price target on Ironwood (IRWD) to $7 from $12 and keeps an Overweight rating on the ...
Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of ...
Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of $460. The firm sees limited upside for the shares in the ...
Empowered Leadership Through the acquisition, xPortal brings seasoned FinTech and crypto innovators Marko Bradic as Co-founder and Chief Product Officer (CPO) and Mohit Tilwani as Co-founder and Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results